Abstract
Heart failure (HF) is one of the major cardiovascular problems, affecting 15 million people worldwide [1,2]. Despite declining mortality from heart disease, the number of patients affected by HF is still increasing [3]. There is an overall 5-year mortality of 50%, and in severe cases this percentage reaches 35%-40% in 1 year [4]. The rates for total mortality and sudden death vary by functional class. In mild HF [New York Heart Association (NYHA) functional class II], the overall annual mortality is 5%-15%, with approximately one-half to two-thirds being classified as sudden. In NYHA class III, the annual mortality increases to 20%-50% and in class IV it often exceeds 50% [5]. Considering the wide spectrum of disease severity in patients with HF, a risk stratification strategy is reasonable to identify those at high risk of cardiac events, in whom more aggressive management may be beneficial. This is especially important for ambulatory patients with moderate-to-severe congestive heart failure (CHF). In this respect, a number of variables have been thorougly investigated. A review of the most commonly used ones will be discussed in this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Erikson H (1995) Heart Failure: growing public health problem. J Intern Med 237:135–141
Ho KKL, Pinsky JL, Kannel WB et al (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22[Suppl]:6A–13A
Kelly DT (1997) Paul Dudley White International Lecture. Our future society: a global challenge. Circulation 95:2459–2464
Braunwald E, Zipes DP, Libby P (2001) Heart disease: a textbook of cardiovascular medicine, 6th ed. W.B. Saunders Company, Pennsylvania, pp 534–561
Uretsky BF, Sheahan RG (1997) Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol 30:1589–1597
Adams KF, Dunlap SH, Suteta CA et al (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788
Bart BA, Shaw LK, McCants CB et al (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008
Young JB (1999) Assessment of heart failure. In: Colucci WS (ed) Cardiac function and dysfunction, 2nd ed. In: Braunwald E (series ed) Atlas of heart diseases. vol 4. Philadelphia, Current Medicine, pp 7.1–7.9
Chomsky DB, Lang CC, Rayos GH et al (1996) Hemodynamic exercise testing: a valuable tool in the selection of cardiac transplantation candidates. Circulation 94:3176–3183
Myers J, Gullestad L (1998) The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure. Curr Opin Cardiol 13:145–155
Myers J, Gullestad L, Vagelos R et al (1998) Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129:286–293
Mancini DM, Eisen H, Kussmaul W et al (1991) Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786
Kao W, Winkle EM, Johnson MR et al (1997) Role of maximal oxygen consumption in establishment of heart transplantation candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol 79:1124–1127
Corra U, Mezzani A, Bosimini E et al (2002) Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 143:418–426
Robbins M, Francis G, Pashkow FJ et al (1999) Ventilatory and heart rate responses and exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 100:2411–2417
Priori SG, Aliot E, Blomstrom-Lundqvist C et al (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–1450
Yap Y, Duong T, Bland M et al (2000) Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long-term but not short-term all-cause, cardiac and arrhythmic mortality after myocardial infarction - a secondary meta-analysis of 2828 patients. Heart 83:55
Copie X, Hnatkova K, Staunton A et al (1996) Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 27:270–276
The Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309–331–336
Stevenson WG, Ridker PM (1996) Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists ? JAMA 14:481–485
Zaret BL, Wackers FJ, Terrin ML et al (1995) Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol 26:73–79
Copie X, Hnatkova K, Staunton A et al (1996) Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two year follow-up study. J Am Coll Cardiol 27:270–276
Mukharji J, Rude RE, Poole WK et al (1984) Risk factors for sudden death after acute myocardial infarction: Two year follow-up. Am J Cardiol 54:31–36
Bigger JT (1986) Prevalence, characteristics and significance of ventricular tachycardia detected by 24 hour continuous electrocardiographic recordings in the late post hospital phase of acute myocardial infarction. Am J Cardiol 58:1151–1160
La Royere MT, Mortara A, Bigger JT Jr et al (1998) The prognostic value of baroreflex sensitvity and heart rate variability after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351:478–484
Polak JF, Holman L, Wynne J, Colucci WS (1983) Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 2:217–224
De Groote P, Millaire A, Foucer-Hossein C et al (1998) Right ventricular ejection farction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 32:948–954
Gavazzi A, Berzuini C, Campana C et al (1997) Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant 16:774–785
Ghio S, Gavazzi A, Campana C et al (2001) Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37:183–188
Lavine SJ, Arends D (1989) Importance of left ventricular filling pressure on diastolic filling in idiopathic dilated cardiomyopathy. Am J Cardiol 64:61–65
Channer KS, Wilde P, Culling W et al (1986) Estimation of left ventricular end-diastolic pressure by pulsed Doppler ultrasound. Lancet 3:1005–1007
Shen WF, Tribouilloy C, Rey JL et al (1992) Prognostic significance of Doppler-derived left ventricular filling variables in dilated cardiomyopathy. Am Heart J 124:1524–1533
Hansen A, Haass M, Zugck C et al (2001) Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 37:1049–1055
Takenada K, Dabestani A, Gardin JM et al (1986) Pulsed Doppler echocardiographic study of left ventricular filling in dilated cardiomyopathy. Am J Cardiol 58:143–147
Masuyama T, Popp RL (1997) Doppler evaluation of left ventricular filling in congestive heart failure. Eur Heart J 18:1548–1556
Dini FK, Michelassi C, Micheli G. et al (2000) Prognostic value of pulmonary venous flow doppler signal in left ventricular dysfunction. J Am Coll Cardiol 36:1295–1302
Rossvol O, Hatle LK (1993) Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol 21:1679–1700
Cecconi M, Manfrin M, Zanoli R et al (1996) Doppler echocardiographic evaluation of left-ventricular end-diastolic pressure in patients with coronary artery disease. J Am Soc Echocardiogr 9:241–250
Cohn JN, Levine TB, Olivari MT et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823
Cohn IN, Johnson GR, Shabetai R et al (1993) Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87:V15–V16
Packer M, Lee WH, Kessler PD et al (1987) Role of neurohumoral mechanisms in determining survival in patients with severe chronic heart failure. Circulation 75: IV80–IV92
Gottlieb SS, Kukin ML, Ahern D et al (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:1534–1539
Tsutamoto T, Wada A, Maeda L et al (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509–516
Hulsmann M, Stanek B, Frey B et al (1998) Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis in patients with chronic heart failure. J Am Coll Cardiol 32:1695–1700
Tsutamoto T, Hisanaga T, Wada A et al (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398
Globits S, Frank H, Pacher B et al (1998) Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure. Am Heart J 135:592–597
Lerman A, Gibbons RJ, Rodeheffer RJ et al (1993) Circulating N terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction. Lancet 341:1105–1109
Yu CM, Sanderson JE (1999) Plasma brain natriuretic peptide-independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Failure 1:59–65
Hülsmann M, Berger R, Sturm B et al (2002) Prediction of outcome by neurohormonal activation, the six-minute walk and the Minnesota Living with Heart Failure Questionairre in an outpatient cohort with congestive heart failure. Eur Heart J 23:886–891
Dao Q, Krishnaswamy P, Kazanegra R et al (2001) Utility of B-natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol 37:379–385
Stanek B, Frey B, Hulssman M et al (2001) Prognostic evaluation of of neurohormonal plasma levels before beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 38:436–442
Koglin J, Pehlivanli S, Schwaiblmair M et al (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38:1934–1941
Aaronson KD, Schwartz IS, Chen TM et al (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667
Ishii J, Nomura M, Nakmura Y et al (2002) Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89:691–695
Likoff MJ, Chandler SL, Kay MR (1987) Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 59:634–638
Campana C, Gavazzi A, Berzuini C et al (1993) XXXPredictors of prognosis in patients awaiting heart transplantation J Heart Lung Transplant 12:756–765
Setsuta K, Seino Y, Takahashi N et al (1999) Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84:608–611
Vecchia LL, Mezzena G, Zonalla L et al (2000) Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 19:644–652
Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189
Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131–1141
Floras JS (1993) Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 87[Suppl VI]:VI40–VI48
Task Force of The European Society of Cardiology and the The North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Eur Heart J 17:354–381
Casolo G, Balli E, Taddei T et al (1989) Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 64:1162–1167
Kienzle MG, Ferguson DW, Birkett CL et al (1992) Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 69:761–767
Nolan J, Batin PD, Andrews R et al (1998) Prospective study of heart rate variability and mortality in chronic heart failure. Circulation 98:1510–1516
Brouwer J, van Veldhuisen DJ, Man in`t Veld AJ et al (1996) Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 28:1183–1189
Szabo BM, van Veldhuisen DJ, van der Veer N et al (1997) Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 79:978–980
Ponikowski P, Aker DS, Chua TP et al (1997) Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dialted cardiomyopathy. Am J Cardiol 79:1645–1650
Fauchier L, Babuty D, Cosnay P et al (1999) Prognostic value of heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 33:1203–1207
Bilchick KC, Fetics B, Djoukeng R et al (2002) Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ survival trial of of antiarrhythmic therapy in congestive heart failure). Am J Cardiol 90:24–28
Shepherd JT (1990) Heart failure: role of cardiovascular reflexes. Cardioscience 1:7–12
Thames MD, Kinugawa T, Smith ML et al (1993) Abnormalities of baroreflex control in heart failure. J Am Coll Cardiol 22A:56A–60A
Marin-Neto JA, Pintya AO, Gallo L Jr et al (1991) Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation. Am J Cardiol 67:604–610
Ellenbogen KA, Mohanty PK, Szentpetery S et al (1989) Arterial baroreflex abnormalities in heart failure: reversal after orthotropic heart transplantation. Circulation 79:51–58
La Royere MT, Mortara A, Schwartz PJ (1995) Baroreflex sensitivity. J Cardiovasc Electrophysiol 6:761–774
Levy MN, Schwartz PJ (eds) (1994) Vagal control of the heart: experimental basis and clinical implications. Futura, Armonk, NY, pp 644
La Royere MT, Specchia G, Mortara A et al (1988) Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation 78:816–824
Mortara A, La Royere MT, Pinna DG et al (1997) Arterial baroreflex modulation of heart rate in chronic heart failure. Circulation 96:3450–3458
Yap YG, Camm AJ (1998) The importance of the autonomic nervous system for risk stratification of post-myocardial infarction patients. Coron Artery Dis 9:353–358
Ponikowski P, Chua TP, Piepoli M et al (1997) Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96:2586–2594
Schmidt G, Malik M, Barthel P et al (1999) Heart-rate turbulence after ventricular premature beats as a predictor of mortality after myocardial infarction. Lancet 353:1390–1396
Davies LC, Francis DP, Ponikowski P et al (2001) Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol 87:737–742
Lown B, Verrier RL (1976) Neural activity and ventricular fibrillation. N Engl J Med 294:1165–1170
Corr PB, Yamada KA, Witkowski FX (1986) Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis. In: Fozzard HA, Haber E, Jennings RB, Katz AN, Morgan HD (eds) The heart and cardiovascular system. Raven, New York pp 1343–1403
Iuliano S, Fischer SG, Karasik PE et al (2002) QRS duration and mortality in patients with congestive heart failure. Am Heart J 143:1085–1091
Gottipaty V, Krelis S, Lu F et al (1993) The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure. J Am Coll Cardiol 33[Suppl A]:145A
Grines CL, Bashore TM, Boudoulas H et al (1989) Functional abnormalities in isolated left bundle-branch block. The effect of interventricular asynchrony. Circulation 79:845–853
Xiao HB, Lee CH, Gibson DG et al (1991) Effect of left-bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 66:443–447
Baldasseroni S, Opasich C, Gorini M et al (2002) Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network of Congestive Heart Failure. Am Heart J 143:398–405
Blanc JJ, Etienne Y, Gilard M et al (1997) Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 96:3273–3277
Saxon LA, Boehmer JP, Hummel J et al (1999) Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol 83:120D-3
Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880
Day CP, McComb JM, Campbell RW et al (1990) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342–344
Kannel WB, Plehn JF, Cupples LA (1998) Cardiac failure and sudden death in the Framingham Study. Am Heart J 115:869–875
Barr CS, Naas A, Freeman M et al (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329
Pye M, Quinn AC, Cobbe SM (1994) QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias ? Br Heart J 71:511–514
Grimm W, Steder U, Menz V et al (1996) QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 78:458–461
Brendorp B, Elming H, Jun Li et al (2001) QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 103:831–835
Fei L, Goldman JH, Prasad K et al (1996) QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 17:258–263
Ho KLL, Anderson KM, Kannel WB et al (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107–115
Rosenbaum DS, Jackson LE, Smith JM et al (1994) Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330:235–241
Hohnloser SH, Klingenheben T, Li Y-G et al (1998) T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 9:1258–1268
Gold MR, Bloomfield Dm, Anderson KP et al (2000) A comparison of T wave alternans, signal averaged electrocardiogarphy and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36:2247–2253
Klingenheben T, Zabel M, D’Agostino RB et al (2000) Predictive value of T wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356:651–652
Teerlink JR, Jalaluddin M, Anderson S et al, on behalf of the PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators (2000) Ambulatory ventricular arrhythmias among patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 101:40–46
Wilson J, Schwartz S, St John Sutton M et al (1983) Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 2:403–410
Doval HC, Nul DR, Grancelli HO et al, for the GESICA-GEMA Investigators (1996) Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 94:3198–3203
Packer M (1985) Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72:681–685
Kannel W, Plehn J, Cupples LA (1988) Cardiac failure and sudden death in the Framingham Study. Am Heart J 115:869–875
Simson MB, Untereker WJ, Spielman SR et al (1983) Relation between late potentials on the body surface and directly recorded fragmanted electrograms in patients with ventricular tachycardia. Am J Cardiol 51:105–112
Kuchard D, Thorburn C, Sammel N (1987) Prediction of serious arrhythmic events after myocardial infarct: signal averaged electrocardiogram, Holter monitoring, and radionuclide ventriculography. J Am Coll Cardiol 9:531–538
Breithart G, Schwarzmaier M, Borgreffe M et al (1983) Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J 4:487–495
Galinier M, Albenque J-P, Afchar N et al (1996) Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J 17:264–271
Middlekauff H, Stevenson W, Woo M et al (1990) Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 66:1113–1117
Mancini D, Wong K, Simson M (1993) Prognostic value of an abnormal signal-averaged electrocardiogram in patients with non-ischemic congestive cardiomyopathy. Circulation 87:1083–1092
Silverman ME, Pressel MD, Brackett JC et al (1995) Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 75:460–464
Poll DS, Marchlinski FE, Buxton AE et al (1986) Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 58:992–997
Stamato NJ, O’Connell JB, Murdock DK et al (1986) The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed ventricular stimulation. Am J Cardiol 112:505–508
Das SK, Morady F, DiCarlo L Jr et al (1986) Prognostic usefulness of programmmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 58:998–1000
Buxton AE, Lee KL, DiCarlo L et al (2000) Electrophysiological testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 342:1937–1945
Schmidt H, Hurst T, Coch M et al (2000) Nonsustained, asymptomatic ventricular tachycardia in patients with coronary artery disease: Prognosis and incidence of sudden death of patients who are noninducible by electrophysiologic testing. Pacing Clin Electrophysiol 23:1220–1225
Zugck C, Krüger C, Kell R et al (2001) Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Failure 3:577–585
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia
About this paper
Cite this paper
Can, I., Aytemir, K., Oto, A. (2003). Risk-Stratification in Heart Failure Patients with Varying Disease Severity. In: Gulizia, M. (eds) New Advances in Heart Failure and Atrial Fibrillation. Springer, Milano. https://doi.org/10.1007/978-88-470-2087-0_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-2087-0_8
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2169-3
Online ISBN: 978-88-470-2087-0
eBook Packages: Springer Book Archive